Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.
CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.
This report contains market size and forecasts of Calcium Antagonists in global, including the following market information:
Global Calcium Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Calcium Antagonists Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Calcium Antagonists companies in 2021 (%)
The global Calcium Antagonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dihydropyridine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Calcium Antagonists include Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Calcium Antagonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Calcium Antagonists Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Calcium Antagonists Market Segment Percentages, by Type, 2021 (%)
- Dihydropyridine
- Diltiazem
- Verapamil
- Others
Global Calcium Antagonists Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Calcium Antagonists Market Segment Percentages, by Application, 2021 (%)
- Hypertension
- Coronary Artery Disease
- Arrhythmia
- Ohers
Global Calcium Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Calcium Antagonists Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Calcium Antagonists revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Calcium Antagonists revenues share in global market, 2021 (%)
Key companies Calcium Antagonists sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Calcium Antagonists sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Aventis
- Searle
- Bayer
- AstraZeneca
- Knoll Pharmaceuticals
- Wyeth-Ayerst
- Novartis
- Sanofi
- Baiyunshan Pharmaceutical
- South China Pharmaceutical Group
- Tianjin Tanabe Seiyaku
Calcium Antagonists Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Calcium Antagonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Calcium Antagonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Calcium Antagonists Overall Market Size
2.1 Global Calcium Antagonists Market Size: 2021 VS 2028
2.2 Global Calcium Antagonists Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Calcium Antagonists Sales: 2017-2028
3 Company Landscape
3.1 Top Calcium Antagonists Players in Global Market
3.2 Top Global Calcium Antagonists Companies Ranked by Revenue
3.3 Global Calcium Antagonists Revenue by Companies
3.4 Global Calcium Antagonists Sales by Companies
3.5 Global Calcium Antagonists Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Calcium Antagonists Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Calcium Antagonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Calcium Antagonists Players in Global Market
3.8.1 List of Global Tier 1 Calcium Antagonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Calcium Antagonists Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Calcium Antagonists Market Size Markets, 2021 & 2028
4.1.2 Dihydropyridine
4.1.3 Diltiazem
4.1.4 Verapamil
4.1.5 Others
4.2 By Type - Global Calcium Antagonists Revenue & Forecasts
4.2.1 By Type - Global Calcium Antagonists Revenue, 2017-2022
4.2.2 By Type - Global Calcium Antagonists Revenue, 2023-2028
4.2.3 By Type - Global Calcium Antagonists Revenue Market Share, 2017-2028
4.3 By Type - Global Calcium Antagonists Sales & Forecasts
4.3.1 By Type - Global Calcium Antagonists Sales, 2017-2022
4.3.2 By Type - Global Calcium Antagonists Sales, 2023-2028
4.3.3 By Type - Global Calcium Antagonists Sales Market Share, 2017-2028
4.4 By Type - Global Calcium Antagonists Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Calcium Antagonists Market Size, 2021 & 2028
5.1.2 Hypertension
5.1.3 Coronary Artery Disease
5.1.4 Arrhythmia
5.1.5 Ohers
5.2 By Application - Global Calcium Antagonists Revenue & Forecasts
5.2.1 By Application - Global Calcium Antagonists Revenue, 2017-2022
5.2.2 By Application - Global Calcium Antagonists Revenue, 2023-2028
5.2.3 By Application - Global Calcium Antagonists Revenue Market Share, 2017-2028
5.3 By Application - Global Calcium Antagonists Sales & Forecasts
5.3.1 By Application - Global Calcium Antagonists Sales, 2017-2022
5.3.2 By Application - Global Calcium Antagonists Sales, 2023-2028
5.3.3 By Application - Global Calcium Antagonists Sales Market Share, 2017-2028
5.4 By Application - Global Calcium Antagonists Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Calcium Antagonists Market Size, 2021 & 2028
6.2 By Region - Global Calcium Antagonists Revenue & Forecasts
6.2.1 By Region - Global Calcium Antagonists Revenue, 2017-2022
6.2.2 By Region - Global Calcium Antagonists Revenue, 2023-2028
6.2.3 By Region - Global Calcium Antagonists Revenue Market Share, 2017-2028
6.3 By Region - Global Calcium Antagonists Sales & Forecasts
6.3.1 By Region - Global Calcium Antagonists Sales, 2017-2022
6.3.2 By Region - Global Calcium Antagonists Sales, 2023-2028
6.3.3 By Region - Global Calcium Antagonists Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Calcium Antagonists Revenue, 2017-2028
6.4.2 By Country - North America Calcium Antagonists Sales, 2017-2028
6.4.3 US Calcium Antagonists Market Size, 2017-2028
6.4.4 Canada Calcium Antagonists Market Size, 2017-2028
6.4.5 Mexico Calcium Antagonists Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Calcium Antagonists Revenue, 2017-2028
6.5.2 By Country - Europe Calcium Antagonists Sales, 2017-2028
6.5.3 Germany Calcium Antagonists Market Size, 2017-2028
6.5.4 France Calcium Antagonists Market Size, 2017-2028
6.5.5 U.K. Calcium Antagonists Market Size, 2017-2028
6.5.6 Italy Calcium Antagonists Market Size, 2017-2028
6.5.7 Russia Calcium Antagonists Market Size, 2017-2028
6.5.8 Nordic Countries Calcium Antagonists Market Size, 2017-2028
6.5.9 Benelux Calcium Antagonists Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Calcium Antagonists Revenue, 2017-2028
6.6.2 By Region - Asia Calcium Antagonists Sales, 2017-2028
6.6.3 China Calcium Antagonists Market Size, 2017-2028
6.6.4 Japan Calcium Antagonists Market Size, 2017-2028
6.6.5 South Korea Calcium Antagonists Market Size, 2017-2028
6.6.6 Southeast Asia Calcium Antagonists Market Size, 2017-2028
6.6.7 India Calcium Antagonists Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Calcium Antagonists Revenue, 2017-2028
6.7.2 By Country - South America Calcium Antagonists Sales, 2017-2028
6.7.3 Brazil Calcium Antagonists Market Size, 2017-2028
6.7.4 Argentina Calcium Antagonists Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Calcium Antagonists Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Calcium Antagonists Sales, 2017-2028
6.8.3 Turkey Calcium Antagonists Market Size, 2017-2028
6.8.4 Israel Calcium Antagonists Market Size, 2017-2028
6.8.5 Saudi Arabia Calcium Antagonists Market Size, 2017-2028
6.8.6 UAE Calcium Antagonists Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Calcium Antagonists Major Product Offerings
7.1.4 Pfizer Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Aventis
7.2.1 Aventis Corporate Summary
7.2.2 Aventis Business Overview
7.2.3 Aventis Calcium Antagonists Major Product Offerings
7.2.4 Aventis Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.2.5 Aventis Key News
7.3 Searle
7.3.1 Searle Corporate Summary
7.3.2 Searle Business Overview
7.3.3 Searle Calcium Antagonists Major Product Offerings
7.3.4 Searle Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.3.5 Searle Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Calcium Antagonists Major Product Offerings
7.4.4 Bayer Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.4.5 Bayer Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Calcium Antagonists Major Product Offerings
7.5.4 AstraZeneca Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Knoll Pharmaceuticals
7.6.1 Knoll Pharmaceuticals Corporate Summary
7.6.2 Knoll Pharmaceuticals Business Overview
7.6.3 Knoll Pharmaceuticals Calcium Antagonists Major Product Offerings
7.6.4 Knoll Pharmaceuticals Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.6.5 Knoll Pharmaceuticals Key News
7.7 Wyeth-Ayerst
7.7.1 Wyeth-Ayerst Corporate Summary
7.7.2 Wyeth-Ayerst Business Overview
7.7.3 Wyeth-Ayerst Calcium Antagonists Major Product Offerings
7.7.4 Wyeth-Ayerst Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.7.5 Wyeth-Ayerst Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Calcium Antagonists Major Product Offerings
7.8.4 Novartis Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Calcium Antagonists Major Product Offerings
7.9.4 Sanofi Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Key News
7.10 Baiyunshan Pharmaceutical
7.10.1 Baiyunshan Pharmaceutical Corporate Summary
7.10.2 Baiyunshan Pharmaceutical Business Overview
7.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Major Product Offerings
7.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.10.5 Baiyunshan Pharmaceutical Key News
7.11 South China Pharmaceutical Group
7.11.1 South China Pharmaceutical Group Corporate Summary
7.11.2 South China Pharmaceutical Group Calcium Antagonists Business Overview
7.11.3 South China Pharmaceutical Group Calcium Antagonists Major Product Offerings
7.11.4 South China Pharmaceutical Group Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.11.5 South China Pharmaceutical Group Key News
7.12 Tianjin Tanabe Seiyaku
7.12.1 Tianjin Tanabe Seiyaku Corporate Summary
7.12.2 Tianjin Tanabe Seiyaku Calcium Antagonists Business Overview
7.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Major Product Offerings
7.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Sales and Revenue in Global (2017-2022)
7.12.5 Tianjin Tanabe Seiyaku Key News
8 Global Calcium Antagonists Production Capacity, Analysis
8.1 Global Calcium Antagonists Production Capacity, 2017-2028
8.2 Calcium Antagonists Production Capacity of Key Manufacturers in Global Market
8.3 Global Calcium Antagonists Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Calcium Antagonists Supply Chain Analysis
10.1 Calcium Antagonists Industry Value Chain
10.2 Calcium Antagonists Upstream Market
10.3 Calcium Antagonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Calcium Antagonists Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Calcium Antagonists in Global Market
Table 2. Top Calcium Antagonists Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Calcium Antagonists Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Calcium Antagonists Revenue Share by Companies, 2017-2022
Table 5. Global Calcium Antagonists Sales by Companies, (K Units), 2017-2022
Table 6. Global Calcium Antagonists Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Calcium Antagonists Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Calcium Antagonists Product Type
Table 9. List of Global Tier 1 Calcium Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Calcium Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Calcium Antagonists Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Calcium Antagonists Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Calcium Antagonists Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Calcium Antagonists Sales (K Units), 2017-2022
Table 15. By Type - Global Calcium Antagonists Sales (K Units), 2023-2028
Table 16. By Application - Global Calcium Antagonists Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Calcium Antagonists Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Calcium Antagonists Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Calcium Antagonists Sales (K Units), 2017-2022
Table 20. By Application - Global Calcium Antagonists Sales (K Units), 2023-2028
Table 21. By Region - Global Calcium Antagonists Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Calcium Antagonists Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Calcium Antagonists Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Calcium Antagonists Sales (K Units), 2017-2022
Table 25. By Region - Global Calcium Antagonists Sales (K Units), 2023-2028
Table 26. By Country - North America Calcium Antagonists Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Calcium Antagonists Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Calcium Antagonists Sales, (K Units), 2017-2022
Table 29. By Country - North America Calcium Antagonists Sales, (K Units), 2023-2028
Table 30. By Country - Europe Calcium Antagonists Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Calcium Antagonists Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Calcium Antagonists Sales, (K Units), 2017-2022
Table 33. By Country - Europe Calcium Antagonists Sales, (K Units), 2023-2028
Table 34. By Region - Asia Calcium Antagonists Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Calcium Antagonists Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Calcium Antagonists Sales, (K Units), 2017-2022
Table 37. By Region - Asia Calcium Antagonists Sales, (K Units), 2023-2028
Table 38. By Country - South America Calcium Antagonists Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Calcium Antagonists Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Calcium Antagonists Sales, (K Units), 2017-2022
Table 41. By Country - South America Calcium Antagonists Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Calcium Antagonists Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Calcium Antagonists Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Calcium Antagonists Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Calcium Antagonists Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Calcium Antagonists Product Offerings
Table 48. Pfizer Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Aventis Corporate Summary
Table 50. Aventis Calcium Antagonists Product Offerings
Table 51. Aventis Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Searle Corporate Summary
Table 53. Searle Calcium Antagonists Product Offerings
Table 54. Searle Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bayer Corporate Summary
Table 56. Bayer Calcium Antagonists Product Offerings
Table 57. Bayer Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Calcium Antagonists Product Offerings
Table 60. AstraZeneca Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Knoll Pharmaceuticals Corporate Summary
Table 62. Knoll Pharmaceuticals Calcium Antagonists Product Offerings
Table 63. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Wyeth-Ayerst Corporate Summary
Table 65. Wyeth-Ayerst Calcium Antagonists Product Offerings
Table 66. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Calcium Antagonists Product Offerings
Table 69. Novartis Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sanofi Corporate Summary
Table 71. Sanofi Calcium Antagonists Product Offerings
Table 72. Sanofi Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Baiyunshan Pharmaceutical Corporate Summary
Table 74. Baiyunshan Pharmaceutical Calcium Antagonists Product Offerings
Table 75. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. South China Pharmaceutical Group Corporate Summary
Table 77. South China Pharmaceutical Group Calcium Antagonists Product Offerings
Table 78. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Tianjin Tanabe Seiyaku Corporate Summary
Table 80. Tianjin Tanabe Seiyaku Calcium Antagonists Product Offerings
Table 81. Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Calcium Antagonists Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Calcium Antagonists Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Calcium Antagonists Production by Region, 2017-2022 (K Units)
Table 85. Global Calcium Antagonists Production by Region, 2023-2028 (K Units)
Table 86. Calcium Antagonists Market Opportunities & Trends in Global Market
Table 87. Calcium Antagonists Market Drivers in Global Market
Table 88. Calcium Antagonists Market Restraints in Global Market
Table 89. Calcium Antagonists Raw Materials
Table 90. Calcium Antagonists Raw Materials Suppliers in Global Market
Table 91. Typical Calcium Antagonists Downstream
Table 92. Calcium Antagonists Downstream Clients in Global Market
Table 93. Calcium Antagonists Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Calcium Antagonists Segment by Type
Figure 2. Calcium Antagonists Segment by Application
Figure 3. Global Calcium Antagonists Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Calcium Antagonists Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Calcium Antagonists Revenue, 2017-2028 (US$, Mn)
Figure 7. Calcium Antagonists Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Calcium Antagonists Revenue in 2021
Figure 9. By Type - Global Calcium Antagonists Sales Market Share, 2017-2028
Figure 10. By Type - Global Calcium Antagonists Revenue Market Share, 2017-2028
Figure 11. By Type - Global Calcium Antagonists Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Calcium Antagonists Sales Market Share, 2017-2028
Figure 13. By Application - Global Calcium Antagonists Revenue Market Share, 2017-2028
Figure 14. By Application - Global Calcium Antagonists Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Calcium Antagonists Sales Market Share, 2017-2028
Figure 16. By Region - Global Calcium Antagonists Revenue Market Share, 2017-2028
Figure 17. By Country - North America Calcium Antagonists Revenue Market Share, 2017-2028
Figure 18. By Country - North America Calcium Antagonists Sales Market Share, 2017-2028
Figure 19. US Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Calcium Antagonists Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Calcium Antagonists Sales Market Share, 2017-2028
Figure 24. Germany Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 25. France Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Calcium Antagonists Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Calcium Antagonists Sales Market Share, 2017-2028
Figure 33. China Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 37. India Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Calcium Antagonists Revenue Market Share, 2017-2028
Figure 39. By Country - South America Calcium Antagonists Sales Market Share, 2017-2028
Figure 40. Brazil Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Calcium Antagonists Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Calcium Antagonists Sales Market Share, 2017-2028
Figure 44. Turkey Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Calcium Antagonists Revenue, (US$, Mn), 2017-2028
Figure 48. Global Calcium Antagonists Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Calcium Antagonists by Region, 2020 VS 2027
Figure 50. Calcium Antagonists Industry Value Chain
Figure 51. Marketing Channels
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
